Unresolved disorder model. using A
ATOM    180  CD ALYS    23      27.892  -5.553  67.420  0.50 44.24           C  
Unresolved disorder model. using A
ATOM    181  CE ALYS    23      28.840  -4.670  68.266  0.50 44.70           C  
Unresolved disorder model. using A
ATOM    182  NZ ALYS    23      30.104  -5.377  68.630  0.50 43.49           N  
Unresolved disorder model. using A
ATOM    183  CD BLYS    23      26.608  -6.241  66.072  0.50 44.89           C  
Unresolved disorder model. using A
ATOM    184  CE BLYS    23      25.501  -6.719  67.070  0.50 47.23           C  
Unresolved disorder model. using A
ATOM    185  NZ BLYS    23      25.891  -8.005  67.760  0.50 46.02           N  
Unresolved disorder model. using A
ATOM   2952  CG AMET   377      -0.212  -4.354  67.987  0.50 41.55           C  
Unresolved disorder model. using A
ATOM   2953  SD AMET   377       1.460  -5.072  67.971  0.50 39.20           S  
Unresolved disorder model. using A
ATOM   2954  CE AMET   377       2.479  -3.753  68.546  0.50 39.99           C  
Unresolved disorder model. using A
ATOM   2955  CG BMET   377      -0.271  -4.386  67.968  0.50 43.68           C  
Unresolved disorder model. using A
ATOM   2956  SD BMET   377      -1.203  -5.927  68.251  0.50 47.04           S  
Unresolved disorder model. using A
ATOM   2957  CE BMET   377      -2.915  -5.337  68.552  0.50 45.58           C  

1